Canopy Growth Corporation

TSX:WEED.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.72 +2.26%

+$0.03 today

Market cap
$323.72M
Beta
2.41
P/E (TTM)
-1.8
EPS (TTM)
-$0.76
52W Low $1.18High $3.28

Volume 1.16M

Average 2.07M

WEED.TO Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Canopy Growth CorporationTSX: WEED.TO

Accounts Receivables · Q4 FY2025 · quarter ended Mar 2026

Accounts receivables turns positive

Q4 FY2025 accounts receivables was CA$6.08M, compared with -CA$1.32M a year earlier. Trailing-twelve-month accounts receivables was CA$34.55M.

Context

  • Accounts receivables amounted to 9.0% of revenue in FY2025, up 7.4 pp from a year earlier.
  • Accounts receivables increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly accounts receivables holds near CA$6.08M or moves back toward the trailing-twelve-month quarterly average of CA$8.64M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$6.08M+205.3% QoQ
Last fiscal yearMar 2026
CA$25.69M+672.7% YoY
LTMMar 2026
CA$34.55M+870.4% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+559.8%——
1 year+672.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Receivables history

CAD · from the cash flow

Latest · FY2025
25.69M CAD
Year-over-year change
+672.7%
4-year CAGR
+17.2%

Accounts Receivables vs competitors

How WEED.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +870.4% is the 2nd highest of 8, against a peer median of +133.2%.
  • Accounts receivables amounts to 11.1% of revenue for WEED.TO, versus a peer median of 3.9%.
WEED.TO Competitors
Accounts Receivables for WEED.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$34.55M CAD+870.4%—11.1%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$15.58M CAD+1667.9%—5.7%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$8.15M CAD-224.8%—2.6%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$2.72M USD-76.8%+100.4%5.3%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$1.98M USD+159.2%—3.9%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$1.92M CAD+165.8%-76.6%1.2%
TSND.TOTerrAscend Corp.LTM Mar 2026$1.08M USD+133.2%-23.4%0.4%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$168K CAD-197.7%—6.1%
Peer median (excluding WEED.TO) —+133.2%-23.4%3.9%

Competitors are the stored peer set for WEED.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Net Income(320.49M)(723.36M)(483.68M)(604.14M)(262.91M)
Depreciation & Amortization114.42M80.03M53.18M43.12M36.47M
Deferred Income Tax(8.95M)(5.73M)12.33M7.14M23K
Stock-Based Compensation46.69M25.32M14.18M(4.21M)4.27M
Change in Working Capital165.56M65.85M(38.69M)(41.36M)27.38M
Accounts Receivables13.6M(9.91M)(3.75M)(4.49M)25.69M
Inventory173.19M55.64M1.03M(17.72M)3.71M
Accounts Payables(35.84M)17.63M9.12M(15.48M)(4.35M)
Other Working Capital14.61M2.48M(45.09M)(3.68M)2.34M
Other Non-Cash Items(543.88M)339K160.74M433.7M130.96M
Operating Cash Flow(545.81M)(557.55M)(281.95M)(165.75M)(63.81M)
Capital Expenditures(48.11M)(10.55M)(4M)(11.28M)(5.95M)
Acquisitions (Net)103.2M(9.29M)(955K)(6.97M)(41.54M)
Purchases of Investments(379.41M)(67.15M)(347K)(95.34M)0
Sales of Investments545.99M502.59M78.55M16.43M19M
Other Investing Activities9.15M17.79M167.38M48.9M6.52M
Investing Cash Flow230.82M433.38M241.59M(47.79M)(21.35M)
Debt Repayment(50.76M)16.98M(509.78M)(220.78M)(13.52M)
Common Stock Issued2.7M1.05M81.06M385.39M374.17M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities2.53M(37.72M)(36.34M)(15.96M)(28.24M)
Financing Cash Flow(45.53M)(19.69M)(465.06M)148.66M332.41M
Effect of Forex Changes(18.12M)44.86M(1.29M)8.39M3.62M
Net Change in Cash(378.65M)(99M)(506.71M)(56.49M)250.87M
Free Cash Flow(593.92M)(568.1M)(285.95M)(177.03M)(69.76M)

Canopy Growth Corporation

TSX:WEED.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.